ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Case Report

Case Report: Ascites as a rare initial manifestation of eosinophilic gastroenteritis

[version 1; peer review: 3 approved with reservations]
PUBLISHED 10 Sep 2024
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Introduction

Eosinophilic gastroenteritis is a rare disease characterized by gastrointestinal symptoms and peripheral eosinophilia. It can affect any layer of the gastrointestinal tract. Mucosal, muscular, and sub-serosal subtypes of eosinophilic infiltration are distinguished based on their infiltration depth. Ascites is a characteristic feature of sub-serosal eosinophilic gastroenteritis. However, isolated ascites is a very rare presentation of the disease, making diagnosis challenging.

Case presentation

In this case report, we present a 25-year-old female eosinophilic gastroenteritis patient who initially presented with symptoms and signs of ascites. She also reported seasonal rhinitis, which has been associated with eosinophilic gastroenteritis. She responded effectively to treatment with prednisolone.

Conclusions

This case report highlights the importance of considering rare diseases like eosinophilic gastroenteritis in the differential diagnosis of ascites. Treatment typically involves dietary modifications and corticosteroids. This case also contributes to our understanding of this rare initial presentation of the disease.

Keywords

Ascites, Eosinophilic Ascites, Eosinophilic Gastroenteritis, Eosinophilia

Introduction

Eosinophilic gastroenteritis (EGE) is a rare inflammatory gastrointestinal disease affecting children and adults. It is characterized by the infiltration of the gastrointestinal tract by eosinophils. Although it commonly affects the stomach and the duodenum, the colon and the esophagus can also be affected.1

Herein, we present a 25-year-old female who presented with ascites, weight loss, loss of appetite, and fever for six months. A complete blood count revealed an elevated eosinophil count; ascetic fluid analysis was also significant for eosinophilia. EGE was confirmed with an endoscopically taken biopsy from the stomach and duodenum. The patient was started on prednisolone 30mg p.o/day, with tapering after two weeks, and for a total of 6 weeks. All her symptoms subsided on subsequent follow-ups, and she regained her initial weight.

Prednisolone 20-40mg in divided doses is the first line of treatment in EGE. It achieves symptomatic remission in 80% of cases within a week and normalization of eosinophilia within two weeks.2 Additional therapeutic options include antihistamines, sodium cromoglycate, montelukast, and ketotifen.36 Surgical intervention is reserved for patients with intestinal obstruction.3,7

The clinical course often alternates between periods of remission and relapse, especially when steroid treatment is stopped in approximately half of patients. To minimize steroid-related side effects, steroid-sparing therapies like antihistamines, mast cell inhibitors, leukotriene receptor antagonists, and anti-interleukin drugs, including ketotifen, can be valuable in managing relapses.4,6 In rare instances where steroid therapy is ineffective, total parenteral nutrition or immunosuppressive agents like oral azathioprine or cyclophosphamide may be added to the steroid regimen for patients with widespread mucosal disease.8

Case presentation

A 25-year-old female presented with progressive abdominal distention for six months. She has also had significant weight loss (5 kg/6 months), loss of appetite, and a low-grade intermittent fever. She had watery diarrhea, alternating with intermittent constipation and crampy abdominal pain. There was no history of jaundice, mental status change, leg edema, skin rash, or joint pain. She denied any history of alcohol or intravenous drug use. The patient has had allergic rhinitis since adolescence. She has no history of hepatitis B or C infection nor any personal or family history of liver disease, hypertension, or diabetes. A physical examination was pertinent for a distended abdomen with signs of intraabdominal fluid collection; other systemic examinations were unremarkable.

A complete blood count revealed white blood cells of 5000/μL, with neutrophils and eosinophils accounting for 57% and 11%, respectively. Other parameters, like hematocrit and platelets, were normal. Hepatitis B surface antigen and hepatitis C antibody were negative. Liver and renal function tests were also in the normal ranges. Serum albumin was 3.56 g/dl. Fluid analysis from the ascites showed a total protein of 4.2 g/dl, albumin of 2.73 g/dl, and a total WBC of 1995 cells/μL with polymorphonuclear cells of 10%. SAAG was 0.83. Cytology from peritoneal fluid revealed eosinophilic effusion, with eosinophils contributing to 12% of the inflammatory cells. Stool examinations were normal three times.

The endoscopy examination found small ulcers in the esophagus and a large ulcer in the first part of the duodenum. The lining of the upper stomach appeared inflamed, but there were no other abnormalities. Multiple biopsy samples were taken from the esophagus, stomach, and duodenum. The upper GI endoscopy showed a Forest class III duodenal ulcer with deformity and narrowing. Biopsies from the stomach showed inflamed cystic cell fragments with dense eosinophil infiltration (35/HPF) in the epithelium and lamina propria (Figure 1). The duodenal biopsy revealed fragmented tissue within the villi surrounded by lymphoplasmacytes and edematous lamina propria with eosinophilic infiltrate (20/HPF) (Figure 2). The biopsy taken from the esophagus was inadequate. These findings were suggestive of EGE.

41906d0f-d794-49e5-a3c7-21ac1689895b_figure1.gif

Figure 1. It is a histology from the stomach showing inflamed cystic cell fragments with dense eosinophil infiltration (35/HPF) in the epithelium and lamina propria.

41906d0f-d794-49e5-a3c7-21ac1689895b_figure2.gif

Figure 2. it is duodenal histology showing fragmented tissue within villi surrounded by lymphoplasmacytic, and edematous lamina propria with eosinophilic infiltrate (20/HPF).

Treatment and outcome

The patient was initiated on prednisolone at a dose of 30mg per day. After two weeks of treatment, the prednisolone was tapered by decreasing 5mg per/week (cumulative dose 945mg) and discontinued after a total of seven weeks. Her ascites and abdominal pain significantly improved within two weeks of starting prednisolone therapy. Following the completion of treatment, she regained her weight, and all her symptoms resolved completely.

Discussion

EGE is a rare gastrointestinal disorder that can affect any part of the gastrointestinal tract, and eosinophilic infiltration is the main feature of the disease. Eosinophilic infiltration can affect any layer of the GI tract, with symptoms varying depending on the affected layer.9 Data on the prevalence of EGE is limited due to the rarity of the disease. The prevalence of EGE in the United States is around 22 to 28 per 100,000 people, based on prior survey data.10 Even though the peak onset of the disease is in the third decade of life, it can occur in any age group.11

The prevalence of sub-serosal EGE varies in different studies. According to Klein et al., out of 40 patients with EGE, 57% have mucosal disease, 30% have muscular disease, and only 13% have subserosa diseases.12 A study by Pinte L et al. found that among 171 patients with eosinophilic ascites, 74% had eosinophilic gastroenteritis. The remaining patients had other causes, such as parasitic infections and malignancies.13

Ascites is the most common manifestation of the sub-serosal subtype of eosinophilic gastroenteritis.14 Furthermore, patients with this variant have abdominal bloating, eosinophilia, and a rapid response to corticosteroid therapy.12 Since patients have nonspecific gastrointestinal manifestations, a high index of suspicion is mandatory.

Half of the individuals with EGE have a history of allergy or atopy; a few of them may have IgE specific for food allergens, and they may also have a positive skin test for a specific antigen.15 Our patient has seasonal allergic rhinitis.

Peripheral eosinophilia is present in two-thirds of patients.16 Marked ascitic fluid eosinophilia is common in sub-serosal variants of EGE (45–90%).12,15,17 This patient’s ascitic fluid analysis only shows 12% eosinophils. Eosinophilic infiltration of the GI tract on biopsy is confirmatory after excluding other causes of eosinophilia, such as malignancy, parasitic infestation, and drugs.11

Treatment of EGE is individualized based on patient characteristics. Patients with malabsorption can try an elimination diet. An elimination diet should be tried for at least 4 to 6 weeks. Those who are not responding should be tried on prednisolone (20–40 mg/day); symptoms usually improve within 2 weeks. Prednisolone should be tapered over the next 2 weeks.18

Conclusion

Eosinophilic gastroenteritis should be suspected in a patient with non-specific abdominal symptoms and ascites of unclear etiology. Therapy with corticosteroids reduces the severity and duration of symptoms.

Ethics approval and consent to participate

There are no ethical concerns about this case report.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

All the images used in this manuscript are obtained from the patient, and the authors have informed written consent to publish the images along with the manuscript

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 10 Sep 2024
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Ayalew ZS, Azibte GT, Bekele TT et al. Case Report: Ascites as a rare initial manifestation of eosinophilic gastroenteritis [version 1; peer review: 3 approved with reservations]. F1000Research 2024, 13:1036 (https://doi.org/10.12688/f1000research.150399.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 10 Sep 2024
Views
1
Cite
Reviewer Report 18 Dec 2024
Hüseyin Döngelli, Dokuz Eylul Universitesi, Izmir, Turkey 
Approved with Reservations
VIEWS 1
The authors presenting an interesting case of eosinophilic gastroenteritis with eosinophilic ascites. There are some points that need some polishing.  

Abstract section:
-Firstly, the authors should provide a brief history of case. How the patient get diagnosed ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Döngelli H. Reviewer Report For: Case Report: Ascites as a rare initial manifestation of eosinophilic gastroenteritis [version 1; peer review: 3 approved with reservations]. F1000Research 2024, 13:1036 (https://doi.org/10.5256/f1000research.164970.r345911)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
3
Cite
Reviewer Report 14 Dec 2024
Nicholas Talley, Hunter Medical Research Institute, New South Wales, Australia 
Approved with Reservations
VIEWS 3
This is an interesting case report of presumed eosinophilic  ascites responding to steroids. A very rare disease, this adds to the literature.

Specific comments:
1. The introduction summarizes the case which is repetitive. Please fix the ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Talley N. Reviewer Report For: Case Report: Ascites as a rare initial manifestation of eosinophilic gastroenteritis [version 1; peer review: 3 approved with reservations]. F1000Research 2024, 13:1036 (https://doi.org/10.5256/f1000research.164970.r345912)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
3
Cite
Reviewer Report 18 Nov 2024
Nhu Thi Hanh Vu, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, Vietnam 
Approved with Reservations
VIEWS 3
The manuscript is well-written and presents a case report of a rare initial manifestation of eosinophilic gastroenteritis (EGE) as ascites. The clinical case presentation is thorough and detailed. However, to enhance the scientific rigor and clarity for readers, I recommend ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Vu NTH. Reviewer Report For: Case Report: Ascites as a rare initial manifestation of eosinophilic gastroenteritis [version 1; peer review: 3 approved with reservations]. F1000Research 2024, 13:1036 (https://doi.org/10.5256/f1000research.164970.r332895)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 10 Sep 2024
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.